Literature DB >> 8507418

Neuropsychological performance in symptomatic and asymptomatic HIV infection.

R A Bornstein1, H A Nasrallah, M F Para, C C Whitacre, P Rosenberger, R J Fass.   

Abstract

OBJECTIVE: To examine cognitive function in patients at various stages of HIV infection, and to determine the nature and severity associated with stage of illness.
DESIGN: Subjects were administered an extensive battery of neuropsychological tests.
SUBJECTS: Two hundred and thirty-three HIV-1-infected homosexual/bisexual men and 77 HIV-negative control subjects who had been screened for previous neurological illness. All subjects were volunteers in a longitudinal study of neurobehavioral complications of HIV infection.
RESULTS: Patients with symptomatic infection differed from controls on a large number of measures, and asymptomatic patients had a more circumscribed pattern of deficit. On a summary measure of cognitive impairment, there was a twofold increase in the prevalence of impairment in asymptomatic patients relative to controls, and a fourfold increase in symptomatic patients. Memory and dexterity problems appear to be early features of neurobehavioral dysfunction, and frontal lobe deficits were found in patients with symptomatic infection.
CONCLUSION: These data indicate that there is a steady increase in the prevalence of neurobehavioral abnormalities associated with stage of infection. The pattern of abnormality also varies with disease stage.

Entities:  

Mesh:

Year:  1993        PMID: 8507418     DOI: 10.1097/00002030-199304000-00011

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  24 in total

1.  Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy.

Authors:  D López-Villegas; R E Lenkinski; I Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Cognitive reserve protects against apathy in individuals with human immunodeficiency virus.

Authors:  Miriam E Shapiro; Jeannette R Mahoney; Deena Peyser; Barry S Zingman; Joe Verghese
Journal:  Arch Clin Neuropsychol       Date:  2013-09-09       Impact factor: 2.813

3.  Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status.

Authors:  Terry R Barclay; Charles H Hinkin; Steven A Castellon; Karen I Mason; Matthew J Reinhard; Sarah D Marion; Andrew J Levine; Ramani S Durvasula
Journal:  Health Psychol       Date:  2007-01       Impact factor: 4.267

4.  Mapping mental number line in physical space: vertical and horizontal visual number line orientation in asymptomatic individuals with HIV.

Authors:  Yelena Bogdanova; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Neuropsychologia       Date:  2008-06-04       Impact factor: 3.139

5.  Assessing and treating forgetfulness and cognitive problems in adults with HIV.

Authors:  David E Vance; Pariya L Fazeli; Linda Moneyham; Norman L Keltner; James L Raper
Journal:  J Assoc Nurses AIDS Care       Date:  2013 Jan-Feb       Impact factor: 1.354

Review 6.  [Clinical features, diagnosis and treatment of HIV-induced neuropsychiatric disorders].

Authors:  Hans-Bernd Rothenhäusler
Journal:  Wien Med Wochenschr       Date:  2006-12

7.  Better quality of life with neuropsychological improvement on HAART.

Authors:  Thomas D Parsons; Alyssa J Braaten; Colin D Hall; Kevin R Robertson
Journal:  Health Qual Life Outcomes       Date:  2006-02-24       Impact factor: 3.186

Review 8.  Genetic, transcriptomic, and epigenetic studies of HIV-associated neurocognitive disorder.

Authors:  Andrew J Levine; Stella E Panos; Steve Horvath
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

9.  The Impact of Depressive Symptoms on Neuropsychological Performance Tests in HIV-Infected Individuals: A Study of the Hawaii Aging with HIV Cohort.

Authors:  Sheri M Shimizu; Dominic C Chow; Victor Valcour; Kamal Masaki; Beau Nakamoto; Kalpana J Kallianpur; Cecilia Shikuma
Journal:  World J AIDS       Date:  2011-12-01

10.  ERP evidence of impaired central nervous system function in virally suppressed HIV patients on antiretroviral therapy.

Authors:  Linda L Chao; Joselyn A Lindgren; Derek L Flenniken; Michael W Weiner
Journal:  Clin Neurophysiol       Date:  2004-07       Impact factor: 3.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.